Armenta Bioscience ApS: Financial statements 2025
CVR: 42358444
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Armenta Bioscience ApS (CVR 42358444) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -676,873 and a net result of DKK -1,433,453 compared with DKK -1,393,964 the year before. Equity in the 2025 report amounted to DKK 1,283,993. The solvency ratio was 91.8%. The company had 4 employees in the financial year.
- Gross Profit
- DKK -676,873
- Profit/Loss
- DKK -1,433,453
- Equity
- DKK 1,283,993
- Total Assets
- DKK 1,398,452
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -677 t. | -1.4 mio. | 1.3 mio. | 4 |
| 2024 | - | -434 t. | -1.4 mio. | 684 t. | 3 |
| 2023 | - | 569 t. | -50 t. | -14 t. | 2 |
| 2022 | - | 7 t. | 7 t. | 36 t. | - |
How creditworthy is Armenta Bioscience ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Armenta Bioscience ApS has published its annual report for 2024. Gross profit came to DKK -434,211, and the net result was DKK -1,393,964.
As of April 16, 2025, Accelerace Invest II K/S is registered as an owner of Armenta Bioscience ApS with an ownership share of 5%.
About Armenta Bioscience ApS
Armenta Bioscience ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Gephion Bio ApS and Meat Tomorrow ApS. The management consists of Matias Heide Ankjær and David Valbjørn Christensen. The company's owners include Accelerace Invest II K/S, Kempf ApS and Niklis Holdings ApS. In 2025, the company reported a gross profit of DKK -676,873 and a net result of DKK -1,433,453 compared with DKK -1,393,964 the year before. Equity in the 2025 report amounted to DKK 1,283,993.